News

March 23, 2010 – The U.S. Food and Drug Administration (FDA) recently added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals...

March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's...

March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events...

Organizers of the 2010 ACC Annual Scientific Session, March 13–16 in Atlanta, recently highlighted some of the changes to this year’s program.

On Saturday, March 13, the ACC is hosting the...

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from...

February 12, 2010 - After the U.S. FDA announced it is launching a program designed to reduce unnecessary medical radiation exposure with a focus on computed tomography, nuclear medicine and...

February 11, 2010 – Former president Bill Clinton received two coronary stents today after being admitted to the hospital with chest pain.

February 9, 2010 – The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals without clinically...

February 9, 2010 – Researchers are developing technology that they hope will one day prevent thrombus formation on cardiovascular devices without the use of anticoagulation drugs.

January 21, 2010 – A new minimally invasive therapy using radiofrequency ablation to short-circuit nerves in the kidney arteries shows promise in treating uncontrolled hypertension. The research...

January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand name Flolan for patients suffering from pulmonary arterial hypertension (PAH).

January 11, 2010 – A hypertension drug using a combination of telmisartan/amlodipine, which requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan), may earn 30 percent patient...

January 8, 2010 – Transradial angiography leads to reduced patient complications, faster recovery time and decreased hospital costs, according to cardiologists at the University of Illinois at...

December 14, 2009 – For its unique Return to Work Lab, which focuses on individualized rehabilitation for younger, more active cardiac patients, the Baylor Jack and Jane Hamilton Heart and...

November 23, 2009 – The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio, for the treatment of adult patients with...

November 17, 2009 – The U.S. Food and Drug Administration (FDA) today warned new safety information shows an interaction between the anti-clotting medication clopidogrel (Plavix) and the proton...

The FDA notified healthcare professionals this week that it is investigating energy levels in external biphasic defibrillators with shocks less than or equal to 200 Joules (J), because of reports...

November 10, 2009 – FDA and Edwards Lifesciences notified healthcare professionals this week about the class 1 FDA recall of CardioVations EndoClamp Aortic Catheter, due to the potential that the...

November 10, 2009 – Covidien said yesterday it will voluntarily contraindicate the use of its Optimark gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance...

November 3, 2009 – The FDA said Boston Scientific recently changed the name of the company's Liberté Bare-Metal coronary stent to VeriFLEX, after reports that Liberté Bare-Metal stents were...